ProfileGDS5822 / ILMN_1256538
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 78% 75% 78% 74% 79% 76% 77% 73% 79% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1105.678
GSM1276600PDAC Late Ablation Control 288.875
GSM1276601PDAC Late Ablation Control 3155.178
GSM1276602PDAC Late Ablation 171.774
GSM1276603PDAC Late Ablation 2132.279
GSM1276604PDAC Late Ablation 3104.976
GSM1303940PDAC Late Ablation_anti-CTLA4 198.877
GSM1303941PDAC Late Ablation_anti-CTLA4 288.373
GSM1303942PDAC Late Ablation_anti-CTLA4 3173.679